The offer per share is about 20% more than Biocorp’s closing stock price on June 2. The two companies plan to focus on drug delivery solutions for chronic diseases, such as diabetes.
Novo Nordisk says in talks to acquire French device-maker Biocorp for $165 million Read More »
In a statement, the insurer said it was “unable to scale our financial infrastructure to match the pace of our growth and secure the additional capital required to run our business.”
Friday Health Plans to shut down as state regulators step in Read More »
The combination therapy was added to standard chemotherapy and lowered the risk of progression or death by 37% in newly diagnosed patients with advanced ovarian cancer without BRCA mutations.
ASCO: AstraZeneca Imfinzi-Lynparza Shows Benefit in Phase III Ovarian Cancer Study Read More »
The erroneous letters from telemedicine provider PWNHealth come as Grail’s parent company, Illumina, is facing pressure from regulators and shareholders to divest the liquid biopsy maker.
Grail blames software glitch for patient notifications of incorrect cancer diagnosis Read More »
Un equipo multidisciplinar ha examinado galerías de gran importancia en el volcán de Cumbre Vieja, en la isla de La Palma, del archipiélago español de las Canarias. La inspección ya ha permitido confirmar la presencia de otra sima en la cara norte del volcán …
Primeros pasos en los nuevos tubos volcánicos de La Palma Read More »
Some of the funding is healthcare-related, and major programs like Medicaid and Medicare emerged unscathed after weeks of negotiations between Republicans and Democrats.
Biden signs debt deal, clearing path for $27B in COVID-19 clawbacks Read More »
El síndrome del intestino irritable es una dolencia que padece hasta el 20% de la población y cuyos síntomas son dolor abdominal y hábito intestinal alterado. Aunque no es un síndrome fatal, reduce la calidad de vida de las personas que la sufren y no existen trata …
The analysts warned switching to non-COVID-19 tests will mean entering a competitive market “where larger companies with financial resources have an established installed base.”
Cue Health’s inability to find post-COVID markets for testing prompts Goldman downgrade Read More »
Vorasidenib, acquired from Agios in a $1.8 billion deal, slowed the growth of a certain type of low-grade glioma by 61% in a Phase III trial.
ASCO: French Pharma Serves Up Win for Low-Grade Glioma Patients Read More »
El infarto agudo de miocardio (oclusión brusca de una arteria coronaria) es una patología con elevada incidencia en los países occidentales. Un estudio liderado por el Instituto de Investigación Sanitaria INCLIVA, del Hospital Clínico de Valencia, y el Cen …
Un efecto a largo plazo del infarto de miocardio Read More »
